A5008051351- Influenza Virus Research Studies
- Muscle Physiology and Disorders
- Respiratory viral infections research
- COVID-19 epidemiological studies
- Bacterial Infections and Vaccines
- Pneumonia and Respiratory Infections
- Prosthetics and Rehabilitation Robotics
- Tissue Engineering and Regenerative Medicine
- Data-Driven Disease Surveillance
- Adipose Tissue and Metabolism
- Occupational Health and Safety Research
- Viral Infections and Immunology Research
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Outbreaks Research
- Supply Chain Resilience and Risk Management
- Genetic Neurodegenerative Diseases
- Vibrio bacteria research studies
- Telomeres, Telomerase, and Senescence
- Risk and Safety Analysis
- Viral gastroenteritis research and epidemiology
- Neurogenetic and Muscular Disorders Research
- SARS-CoV-2 detection and testing
- Whipple's Disease and Interleukins
Public Health Agency of Canada
2014-2022
Carter Center
2020-2021
Centers for Disease Control and Prevention
2018-2020
National Center on Birth Defects and Developmental Disabilities
2020
Atlas Copco (United States)
2020
Quest Diagnostics (United States)
2015
An illness was categorized as one compatible with COVID-19 if symptoms met the Council of State and Territorial Epidemiologists (CSTE) clinical criteria in case definition, including 1) cough, shortness breath, or difficulty breathing 2) two more other (fever [measured subjective], chills, rigors, myalgia, headache, sore throat, new olfactory taste disorders).https://cdn.ymaws.com/www.cste.org/resource/resmgr/2020ps/interim-20id-01_covid-19.pdf.reported here does not represent seroprevalence...
The purpose of this report is to provide a summary the pertussis activity in Canada.A descriptive analysis incidence by year, age group, gender and province/territory was conducted using national surveillance data, clinical administrative data vital statistics data.Pertussis an endemic cyclical disease Canada with peaks occurring every 2 5 years. has experienced decline following introduction routine immunization programs. highest infants children. Hospitalization mortality are more common...
The first coronavirus disease 2019 (COVID-19) case was reported in Canada on January 25, 2020. In response to the imminent outbreak, many provincial and territorial health authorities implemented nonpharmaceutical public measures curb spread of disease. "Social distancing" included restrictions group gatherings; cancellation sports, cultural religious events recommended physical distancing between people; school daycare closures; reductions non-essential services; closures businesses.To...
<b><i>Introduction:</i></b> Previous studies indicated variability in the prevalence of Duchenne and Becker muscular dystrophies (DBMD) by racial/ethnic groups. The Centers for Disease Control Prevention’s (CDC) Muscular Dystrophy Surveillance, Tracking, Research network (MD STAR<i>net</i>) conducts dystrophy surveillance multiple geographic areas USA continues to enroll new cases. This provides an opportunity continue investigating differences DBMD race...
Aim To compare acute flaccid paralysis ( AFP ) surveillance systems used by members of the International Network Paediatric Surveillance Units INoPSU across five performance indicators recommended World Health Organization WHO for maintenance polio‐free certification. Methods A survey was administered to co‐ordinators in member countries ustralia, B elgium, C anada, N ew Z ealand and S witzerland). Data collected included information on system processes, ‐recommended indicators,...
Data on muscular dystrophies (MDs), a heterogeneous group of heritable diseases hallmarked by progressive muscle deterioration, are scarce.We describe cross-sectional sociodemographic and clinical characteristics individuals with congenital, distal, Emery-Dreifuss, facioscapulohumeral, limb-girdle, myotonic, or oculopharyngeal MD.The study was conducted in four sites (Arizona, Colorado, Iowa, 12 western New York counties) as pilot expansion the Muscular Dystrophy Surveillance, Tracking...
Contexte : Le premier cas de maladie à coronavirus 2019 (COVID-19) a été signalé au Canada le 25 janvier 2020. En réponse l’imminence d’une éclosion, nombreuses autorités sanitaires provinciales et territoriales ont mis en œuvre des mesures santé publique non pharmaceutiques pour freiner la propagation maladie. Les « distanciation sociale » comprenaient restrictions sur les rassemblements groupes, l’annulation d’événements sportifs, culturels religieux, recommandation du maintien distance...
Canada's national influenza season started in week 47 between November 17 to 23, 2019.Of the 3,762 laboratory-confirmed detections reported from August 25 December 14, 2019, 61% were A, and of those subtyped, 68% A(H3N2).Influenza B are above average for this time year.Indicators activity within expected range year.The majority hospitalizations by provinces territories have been associated with A(H3N2) (76%), greatest proportion among adults 65 years older (40%).Among sentinel pediatric...
In 2012 there was an increase in the incidence of pertussis Americas. The Pan American Health Organization (PAHO) made a number recommendations to strengthen surveillance, investigate outbreaks, measure adequacy and timeliness immunizations within population monitor policies related high risk individuals such as health care workers pregnant women.To review measures taken Canada by provinces territories control prevent spread.A survey developed based on PAHO distributed through Council Chief...
OBJECTIVE: To determine the frequencies and distributions of mutations variants unknown clinical significance (VUS) in COL6A1 , COL6A2 COL6A3 genes specimens analyzed for collagen VI-related congenital muscular dystrophy (CMD) at a laboratory. BACKGROUND: Mutations cause mild to severe continuum disorders including Bethlem myopathy (BM), Ullrich (UCMD), intermediate phenotypes. The genotype/phenotype correlation is challenging due high degree genetic heterogeneity patients with similar...